Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme

Neuron

Volumn 16, Issue 4, 1996, Pages 881-891

  Inestrosa, Nibaldo C ^a   Alvarez, Alejandra ^a   Pérez, Cristián A ^a   Moreno, Ricardo D ^a   Vicente, Matias ^a   Linker, Claudia ^a   Casanueva, Olivia I ^a   Soto, Claudio ^a,b   Garrido, Jorge ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID; AMYLOID BETA PROTEIN; EDROPHONIUM;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CHOLINERGIC SYNAPSE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN QUATERNARY STRUCTURE; SENILE PLAQUE;

EID: 0029863697     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80108-7     Document Type: Article

References (86)

1. Alvarez, A., Bronfman, F., Pérez, C.A., Vicente, M., Garrido, J., and Inestrosa, N.C. (1995). Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides. Neurosci. Lett. 201, 49-52.
2. Amitai, G., and Taylor, P. (1991). Characterization of peripheral anionic site peptides of AChE by photoaffinity labeling with monoazidopropidium (MAP). In Cholinesterases: Structure, Function, Mechanism, Genetics and Cell Biology, J. Massoulié, F. Bacou, E.A. Barnard, A. Chatonnet, B.P. Doctor, and D.M. Quinn, eds. (Washington D.C.: American Chemical Society), p. 285.
3. Arendt, T., Bruckner, M.K., Lange, M., and Bigl, V. (1992). Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development. A study of molecular forms. Neurochem. Int. 21, 381-396.
4. Atack, J.R., Perry, E.K., Bonham, J.R., Perry, R.H., Tomlinson, B.E., Candy, J., Blessed, G., and Fairbairn, A. (1983). Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci. Lett. 40, 199-204.
5. Barak, D., Kronman, C., Ordentlich, A., Ariel, N., Bromberg, A., Marcus, D., Lazar, A., Velan, B., and Shafferman, A. (1994). Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. J. Biol. Chem. 264, 6296-6305.
6. Barrow, C.J., Yasuda, A., Kenny, P.T.M., and Zagorski, M.G. (1992). Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225, 1075-1093.
7. Beeri, R., Andres, C., Lev-Lehman, E., Timberg, R., Huberman, T., Shani, M., and Soreq, H. (1995). Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5, 1063-1071.
8. Bergmann, F., and Segal, R. (1954). The relationship of quaternary ammonium salts to the anionic site of true and pseudo cholinesterase. Biochem. J. 58, 692-698.
9. Bergmann, F., Wilson, I.B., and Nachmansohn, D. (1950). The inhibitory effect of stilbamidine, curare, and related compounds and its relationship to the active groups of acetylcholine esterase: action of stilbamidine upon nerve impulse conduction. Biochim. Biophys. Acta 6, 217-224.
10. Bondi, M.W., Salmon, D.P., and Butters, N.M. (1994). Neuropsychological features of memory disorders in Alzheimer disease. In Alzheimer Disease, R.D. Terry, R. Katzman, and K.L. Bick, eds. (New York: Raven Press), pp. 41-63.
11. Bourne, Y., Taylor, P., Marchot, P. (1995). Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex. Cell 83, 1-10.
12. Brandan, E., and Inestrosa, N.C. (1993). Extracellular matrix components and amyloid in neuritic plaques of the Alzheimer's disease. Gen. Pharmacol. 24, 1063-1068.
13. Brandan, E., Maldonado, M., Garrido, J., and Inestrosa, N.C. (1985). Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans. J. Cell. Biol. 101, 985-992.
14. Carson, K.A., Geula, C., and Mesulam, M.-M. (1991). Electron microscopic localization of cholinesterase activity in Alzheimer brain. Brain Res. 540, 204-208.
15. Castano, E.M., Ghiso, J., Prelli, F., Gorevic, P.D., Migheli, A., and Frangione, B. (1986). In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein. Biochem. Biophys. Res. Commun. 141, 782-786.
16. Castano, E.M., Prelli, F., Wisniewski, T., Golabek, A., Kumar, R.A., Soto, C. and Frangione, B. (1995). Fibrillogenesis in Alzheimer's disease of amyloid-β peptides and apolipoprotein E. Biochem. J. 306, 599-604.
17. Changeux, J.P. (1966). Responses of acetylcholinesterase from Torpedo marmorata to salts and curarizing drugs. Mol. Pharmacol. 2, 369-392.
18. Chatonnet, A., and Lockridge, O. (1989). Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 260, 625-634.
19. Coyle, J.T., Price, D.L., and Delong, M.R. (1983). Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219, 1184-1190.
20. Deprez, P., and Inestrosa, N.C. (1995). Two heparin-binding domains are present on the collagenic tail of asymmetric acetylcholinesterase. J. Biol. Chem. 270, 11043-11046.
21. Eichler, J., Anselmet, A., Sussman, J.L., Massoulié, J., and Silman, I. (1994). Differential effects of 'peripheral' site ligands on Torpedo and chicken acetylcholinesterase. Mol. Pharmacol. 45, 335-340.
22. Ellman, G.L., Courtney, K.D., Andres, V., and Featherstone, R.M. (1961). A new rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
23. Evans, K.C., Berger, E.P., Cho, C.-G., Weisgraber, K.L., and Lansbury, P.T. (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 763-767.
24. Fishman, E.B., Siek, G.C., MacCallum, R.D., Bird, E.D., Volicer, L., and Marquis, J.K. (1986). Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann. Neurol. 19, 246-252.
25. 4 acetylcholinesterase. Biochem. J. 256, 1047-1050.
26. Geula, C., and Mesulam, M.-M. (1989). Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res. 198, 185-189.
27. Geula, C., and Mesulam, M.-M. (1994). Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In Alzheimer Disease, R.D. Terry, R. Katzman, and K.L. Bick, eds. (New York: Raven Press), pp. 263-291.
28. Ghiso, J., Matsubara, E., Koudinov, A., Wisniewski, T.,and Frangione, B. (1993). The cerebrospinal fluid soluble form of Alzheimer's amyloid b is complexed to SP40, 40 (ApoJ), an inhibitor of the complement membrane attack complex. Biochem. J. 293, 27-30.
29. Gómez-Ramos, P., Mufson, E.J., and Morán, M.A. (1992). Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain. Brain Res. 569, 229-237.
30. Hall, Z.W., and Kelly, R.B. (1971). Enzymatic detachment of endplate acetylcholinesterase from muscle. Nature New Biol. 232, 62.
31. Harel, M., Silman, I., and Sussman, J.L. (1992). A model of butyrylcholinesterase based on the X-ray structure of acetylcholinesterase indicates differences in specificity. In Multidisciplinary Approaches to Cholinesterase Functions, A. Shafferman and B. Velan, eds. (New York: Plenum Press), pp. 233-242.
32. Harel, M., Kleywegt, G.J., Ravelli, R.B.G., Silman, I., and Sussman, J. (1995). Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target. Structure 3, 1355-1366.
33. Inestrosa, N.C., and Perelman, A. (1989). Distribution and anchoring of molecular forms of acetylcholinesterase. Trends Pharmacol. Sci. 10, 325-329.
34. Inestrosa, N.C., and Perelman, A. (1990). Association of acetylcholinesterase with the cell surface. J. Memb. Biol. 118, 1-9.
35. Inestrosa, N.C., Miller, J.B., Silberstein, L., Ziskind-Conhaim, L., and Hall, Z.W. (1983). Development and regulation of 16 S acetylcholinesterase and acetylcholine receptors in a mouse muscle cell line. Exp. Cell Res. 147, 393-406.
36. Inestrosa, N.C., Roberts, W.L., Marshall, T.L., and Rosenberry, T.L. (1987). Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterase in othertissues. J. Biol. Chem. 262, 4441-4444.
37. Inestrosa, N.C., Fuentes, M.E., Anglister, L., Futerman, A.H., and Silman, I. (1988). A membrane-associated dimer of acetylcholinesterase from Xenopus skeletal muscle is solubilized by phosphatidylinositol-specific phospholipase c. Neurosci. Lett. 90, 186-190.
38. Iversen, L.L., Mortishire-Smith, R.J., Pollack, S.J., and Shearman, M.S. (1995). The toxicity in vitro of β-amyloid protein. Biochem. J. 311, 1-16.
39. Jarrett, J.T., and Lansbury, P.T. (1993). Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and Scrapie? Cell 73, 1055-1058.
40. Jarrett, J.T., Berger, E.P., and Lansbury, P.T., Jr. (1993). The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
41. Kalaria, R.N., Galloway, P.G., and Perry, G. (1991). Widespread amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Neuropathol. Appl. Neurobiol. 17, 189-201.
42. Katzman, R., and Kawas, C.H. (1994). The epidemiology of dementia and Alzheimer disease. In Alzheimer Disease, R.D. Terry, R. Katzman, and K.L. Bick, eds. (New York: Raven Press), pp. 105-122.
43. Kirschner, D.A., Inouye, H., Duffy, L.K., Sinclair, A., Linda, M., and Selkoe, D.J. (1987). Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 84, 6953-6957.
44. Lansbury, P.T. (1992). In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information. Biochemistry 31, 6865-6870.
45. Layer, P.G., Weikert, T., and Alber, R. (1993). Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell Tissue Res. 273, 219-226.
46. LeVine, H. (1993). Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2, 404-410.
47. Levy, E., Carman, M., Fernández-Madrid, I., Power, M., Lieberburg, I., van Duinen, S., Gerard, T., Bots, A., Luyendijk, W., and Frangione, B. (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1128.
48. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
49. Main, A.R. (1976). Structure and inhibitors of cholinesterase. In Biology of Cholinergic Function, A.M. Goldberg and I. Hanin, eds. (New York: Raven Press), pp. 269-353.
50. Massoulié, J., Pezzementi, L., Bon, S., Krejci, E., and Vallette, F. -M. (1993). Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41, 31-91.
51. Mesulam, M.-M. (1986). Alzheimer plaques and cortical cholinergic innervation. Neuroscience 17, 275-276.
52. Mesulam, M.-M., Geula, Ch., and Moran, M.A. (1987). Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann. Neurol. 22, 683-691.
53. Mesulam, M.-M., and Geula, C. (1988). Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus: absence at birth, development during the life span, and dissolution in Alzheimer's disease. Ann. Neurol. 24, 765-773.
54. Moran, M.A., Mufson, E.J., and Gómez-Ramos, P. (1993). Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brain. Acta Neuropathol. 85, 362-369.
55. Naiki, H., Higuchi, K., Nakakuki, K., and Takeda, T. (1991). Kinetic analysis of amyloid fibril polymerization in vitro. Lab. Invest. 65, 104-110.
56. Nakamura, S., Kawashima, S., Nakang, S., Tsuji, T., and Araki, W. (1990). Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization. J. Neural Transm. Suppl. 30, 13-23.
57. Navaratnam, D.S., Priddle, J.B., McDonald, B., Esiri, M.M., Robinson, J.R., and Smith, A.D. (1991). Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease. Lancet 337, 447-450.
58. Perry, E.K., Tomlinson, B.E., Blessed, G., Bergmann, K., Gibson, P.H., and Perry, R.H. (1978). Correlation of cholinergic abnormalities with senile plaques and mental scores in senile dementia. Br. Med. J. 2, 1457-1459.
59. Radic, Z., Reiner, E., and Taylor, P. (1991). Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. Mol. Pharmacol. 39, 98-104.
60. Radic, Z., Pickering, N., Vellom, D., Camp, S., and Taylor, P. (1993). Three distinct domains distinguish between acetylcholinesterase and butyrylcholinesterase substrate and inhibitor specificities. Biochemistry 32, 12074-12084.
61. Schagger, H., and von Jagow, G. (1987). Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379.
62. Selkoe, D.J. (1994). Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci 17, 489-517.
63. Shen, Z. -X. (1994). Acetylcholinesterase provides deeper insights into Alzheimer's disease. Med. Hypoth. 43, 21-30.
64. Silman, I., Harel, M., Axelsen, P., Raves, M., and Sussman, J.L. (1994). Three-dimensional structures of acetylcholinesterase and its complexes with anticholinesterase agents. Biochem. Soc. Trans. 22, 745-749.
65. Smith, A.D., and Cuello, A.C. (1984). Alzheimer's disease and acetylcholinesterase-containing neurons. Lancet I, 513.
66. Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J., and Wight, T.N. (1988). The presence of heparan sulfate proteoglycan in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
67. Snow, A.D., Sekiguchi, R., Nochlin, D., Fraser, P., Kimata, K., Mizutani, A., Arai, M., Schreier, W.A., and Morgan, D.G. (1994). An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Αβ-amyloid in rat brain. Neuron 12, 219-234.
68. Soto, C., Branes, C., Alvarez, J., and Inestrosa, N.C. (1994). Structural determinants of the Alzheimer's amyloid β-peptide. J. Neurochem. 63, 1191-1198.
69. Soto, C., Castano, E., Frangione, B., and Inestrosa, N.C. (1995). The α-helical to β-strand transition in the N-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270, 3063-3067.
70. Struble, R.G., Cork, L.C., Whitehouse, P.J., and Price, D.L. (1982). Cholinergic innervation in neuritic plaques. Science 216, 413-415.
71. Sussman, J.L., and Silman, I. (1992). Acetylcholinesterase: structure and use as a model for specific cation-protein interactions. Curr. Opin. Struct. Biol. 2, 721-729.
72. Sussman, J.L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., and Silman, I. (1991). Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253, 872-897.
73. Tagliavini, F, Giaccone, G., Frangione, B., and Bugiani, O. (1988). Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci. Lett. 93, 191-196.
74. Taylor, P., and Lappi, S. (1975). Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. Biochemistry 14, 1989-1997.
75. Taylor, P., and Radic, Z. (1994). The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 34, 281-320.
76. Terry, R.D., Masliah, E., and Hansen, L.A. (1994). Structural basis of the cognitive alterations in Alzheimer disease. In Alzheimer Disease, R.D. Terry, R. Katzman, and K.L. Bick, eds. (New York: Raven Press), pp. 179-196.
77. Velan, B., Grosfeld, H., Kronman, C., Leitner, M., Gozes, Y., Lazar, A., Flashner, Y., Marcus, D., Cohen, S., and Shafferman, A. (1991). The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. J. Biol. Chem. 266, 23977-23984.
78. Vellom, D.C., Radic, Z., Li, Y., Pickering, N.A., Camp, S., and Taylor, P. (1993). Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry 32, 12-17.
79. Weise, C., Kreienkamp, H.J., Raba, R., Pedak, A., Aaviksaar, A., and Hucho, F. (1990). Anionic subsites of the acetylcholinesterase from Torpedo californica. EMBO J. 9, 3885-3888.
80. Whitehouse, P.J., Price, D.L., Clark, A.W., Coyle, J.T., and DeLong, M.R. (1981). Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122-126.
81. Wilson, I.B., and Quan, C. (1958). Acetylcholinesterase studies on molecular complementarity. Arch. Biochem. Biophys. 73, 131-143.
82. Winkler, J., Suhr, S.T., Gage, F.H., Thal, L.J., and Fisher, L.J. (1995). Essential role of acetylcholine in spatial memory. Nature 375, 484-487.
83. Wisniewski, T. and Frangione, B. (1992). Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
84. Wisniewski, T., Guiso, J., and Frangione, B. (1991). Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 173, 1247-1254.
85. Wright, C.I., Geula, C., and Mesulam, M.-M. (1993). Protease inhibitors and indoleamines selectively inhibit cholinesterase in the histophathologic structures of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 683-686.
86. Younkin, S.G., Goodridge, B., Katz, J., Lockett, G., Nafziger, D., Usiak, M.F., and Younkin, L.H. (1986). Molecular forms of acetylcholinesterase in Alzheimer's disease. Fed. Proc. 45, 2982-2988.